The real world risk of AI breastfeeding advice
For sleep-deprived nursing moms, artificial intelligence may feel like a lifeline. In fact, a new national survey from Orlando Health reveals if women ages 18 to 44 had an urgent… read more.
For sleep-deprived nursing moms, artificial intelligence may feel like a lifeline. In fact, a new national survey from Orlando Health reveals if women ages 18 to 44 had an urgent… read more.
Menstrual leave and flexible work arrangements are the forms of support women with endometriosis say would help them most, according to a new study by researchers at Semmelweis University published… read more.
Around one in six people experience infertility, with irregular or absent ovulation among the most common causes. The drug clomiphene citrate has long been a mainstay of fertility treatment, but… read more.
A postpartum care model combining health coaching with self-measured blood pressure (BP) monitoring significantly improved both health care engagement and blood pressure control by 12 months post partum,… read more.
Merck BioPharma K.K., the Japanese subsidiary of Merck KGaA, began participant registration for a Phase III trial evaluating the efficacy and safety of fixed-dose combinations of follitropin alfa… read more.
The type of menopause symptoms, as well as their severity, can differ greatly among women. A number of earlier studies have suggested various reasons for those differences. A… read more.
Pregnant women in Australia are facing an unfair two-tiered system for managing morning sickness, with financial status impacting who can access the full range of modern anti-nausea medications… read more.
7 August 2026 – Astellas Pharma Inc. confirms it has submitted a New Drug Application (NDA) to Japan’s Ministry of Health, Labour and Welfare (MHLW) seeking approval of… read more.
A multi-institutional research team led by Central South University (CSU) and The Chinese University of Hong Kong (CUHK) has unveiled the most comprehensive genomic analysis to date of… read more.
One in eight mothers in England is now diagnosed with gestational diabetes, with diagnoses rising by 60 per cent in just five years, according to a major study…. read more.
Viatris Inc. announced that the FDA has approved Gwyn Lo (norelgestromin and ethinyl estradiol transdermal system). Gwyn Lo is a new combined hormonal contraceptive patch with low-dose estrogen…. read more.
The European Medicines Agency (EMA) has unveiled a series of initiatives designed to address low representation of women in clinical trials and gaps in understanding sex-based differences in… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.